ArticleInvestigational new drugs2025
Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia.
Anran Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.